Rocaglaol induces apoptosis and cell cycle arrest in LNCaP cells

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 947-952

  Mi, Qiuwen ^a   Su, Bao Ning ^a,b   Chai, Heebyung ^a,b   Cordell, Geoffrey A ^a   Farnsworth, Norman R ^a   Kinghorn, A Douglas ^b   Swanson, Steven M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell cycle; G2 M arrest; Rocaglaol

Indexed keywords

BENZOFURAN DERIVATIVE; CASPASE 7; CASPASE 9; CELL CYCLE PROTEIN; MITOCHONDRIAL PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; ROCAGLAOL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL STRAIN LNCAP; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACTINS; AGLAIA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BENZOFURANS; BREAST NEOPLASMS; CASPASES; CELL CYCLE; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MALE; PLANT BARK; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS;

EID: 33645832379     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Swanson SM, Pezzuto JM, Wani MC, Wall ME, Oberlies NH, Kroll DJ, Kramer RA, Rose WC, Vite GD, Fairchild CR, Peterson RW and Wild R: Novel strategies for the discovery of plant-derived anticancer agents. Pharm Biol 41(Suppl): 53-67, 2003.
2. Su BN, Chai H, Mi Q, Riswan S, Kardono LB, Afriastini JJ, Santarsiero BD, Mesecar AD, Farnsworth NR, Cordell GA, Swanson SM and Kinghorn AD: Activity-guided isolation of cytotoxic constituents from the bark of Aglaia crassinervia collected in Indonesia. Bioorg Med Chem 14: 960-972, 2006.
3. Ishibashi F, Satasook C, Isman MB and Towers GHN: Insecticidal 1H-cyclopentatetrahydro[b]benzofurans from Aglaia odorata. Phytochemistry 32: 307-310, 1993.
4. Debatin K: Activation of apoptosis pathways by anticancer treatment. Toxicol Lett 112-113: 41-48, 2000.
5. Guchelaar HJ, Vermes A, Vermes I and Haanen C: Apoptosis: molecular mechanisms and implications for cancer chemotherapy. Pharm World Sci 19: 119-125, 1997.
6. Jaffrezou JP, Bettaieb A, Levade T and Laurent G: Antitumor agent-induced apoptosis in myeloid leukemia cells: a controlled suicide. Leuk Lymphoma 29: 453-463, 1998.
7. 2/M transition by p53. Oncogene 20: 1803-1815, 2001.
8. Woynarowska BA and Woynarowski JM: Preferential targeting of apoptosis in tumor versus normal cells. Biochim Biophys Acta 1587: 309-317, 2002.
9. Lecoeur H: Nuclear apoptosis detection by flow cytometry: influence of endogenous endonucleases. Exp Cell Res 277: 1-14, 2002.
10. Liu X, Yue P, Zhou Z, Khuri FR and Sun SY: Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 96: 1769-1780, 2004.
11. Rajendra S, Mulcahy H, Patchett S and Kumar P: The effect of H2 antagonists on proliferation and apoptosis in human colorectal cancer cell lines. Dig Dis Sci 49: 1634-1640, 2004.
12. Saraste A: Morphologic criteria and detection of apoptosis. Herz 24: 189-195, 1999.
13. Saraste A and Pulkki K: Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res 45: 528-537, 2000.
14. Khokhar S and Chawla R: Apoptosis: an ocular perspective. Natl Med J India 15: 148-153, 2002.
15. Loo DT and Rillema JR: Measurement of cell death. Methods Cell Biol 57: 251-264, 1998.
16. Kapuscinski J: DAPI: a DNA-specific fluorescent probe. Biotech Histochem 70: 220-233, 1995.
17. Reddy BS, Sondhi SM and Lown JW: Synthetic DNA minor groove-binding drugs. Pharmacol Ther 84: 1-111, 1999.
18. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
19. Shankar S, Chen X and Srivastava RK: Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo. Prostate 62: 165-186, 2005.
20. Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T and Yuan J: Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol 3: 173-182, 2001.
21. Basanez G, Zhang J, Chau BN, Maksaev GI, Frolov VA, Brandt TA, Burch, J, Hardwick JM and Zimmerberg J: Proapoptotic cleavage products of Bcl-xL form cytochrome c-conducting pores in pure lipid membranes. J Biol Chem 276: 31083-31091, 2001.
22. Pellecchia M and Reed JC: Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapy. Curr Pharm Des 10: 1387-1398, 2004.
23. Kuida K: Caspase-9. Int J Biochem Cell Biol 32: 121-124, 2000.
24. Satoh MS and Lindahl T: Role of poly(ADP-ribose) formation in DNA repair. Nature 356: 356-358, 1992.
25. Sallmann FR, Bourassa S. Saint-Cyr J and Poirier GG: Characterization of antibodies specific for the caspase cleavage site on poly(ADP-ribose) polymerase: specific detection of apoptotic fragments and mapping of the necrotic fragments of poly(ADP-ribose) polymerase. Biochem Cell Biol 75: 451-456, 1997.
26. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G and Murcia JM: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273: 33533-33539, 1998.
27. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D and Boyd MR: Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48: 4827-4833, 1988.
28. Seo EK, Kim NC, Mi Q, Chai H, Wall ME, Wani MC, Navarro HA, Burgess JP, Graham JG, Cabieses F, Tan GT, Farnsworth NR, Pezzuto JM and Kinghorn AD: Macharistol, a new cytotoxic cinnamylphenol from the stems of Machaerium aristulatum. J Nat Prod 64: 1483-1485, 2001.
29. Mi Q, Cui B, Lantvit D, Reyes-Lim E, Chai H, Pezzuto JM, Kinghorn AD and Swanson SM: Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance. Anticancer Res 23: 3607-3615, 2003.
30. Wilson WD, Tanious FA, Barton HJ, Wydra RL, Jones RL, Boykin DW and Strekowski L: The interaction of unfused polyaromatic heterocycles with DNA: intercalation, groove-binding and bleomycin amplification. Anticancer Drug Des 5: 31-42, 1990.
31. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 184: 39-51, 1995.
32. Gajate C, An F and Mollinedo F: Differential cytostatic and apoptotic effects of ecteinascidin-743 in cancer cells. Transcription-dependent cell cycle arrest and transcription-independent JNK and mitochondrial mediated apoptosis. J Biol Chem 277: 41580-41589, 2002.
33. Ren S, Gao C, Zhang L, Koike K and Tsuchida N: PI3K inhibitors changed the p53-induced response of Saos-2 cells from growth arrest to apoptosis. Biochem Biophys Res Commun 308: 120-125, 2003.
34. Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, Coad JE, Flynn DC, Reed E and Li QQ: Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci 62: 881-893, 2005.
35. Yuan SY, Hsu SL, Tsai KJ and Yang CR: Involvement of mitochondrial pathway in Taxol-induced apoptosis of human T24 bladder cancer cells. Urol Res 30: 282-288, 2002.
36. Boatright KM and Salvesen GS: Mechanisms of caspase activation. Curr Opin Cell Biol 15: 725-731, 2003.
37. Sumantran VN, Lee DS, Woods Ignatoski KM, Ethier SP and Wicha MS: A bcl-xS adenovirus selectively induces apoptosis in transformed cells compared to normal mammary cells. Neoplasia 2: 251-260, 2000.